Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2012

View Archived Issues

AstraZeneca highlights key events of fourth quarter and FY2011

Japanese study compares drugs to retard symptom progression after stroke

Carbon nanomaterials display antioxidant characteristics

Pfizer prepares new voltage-gated K(V)7.2 and K(V)7.3 potassium channel openers

New melanin-concentrating hormone MCH1 receptor modulators disclosed

Mitsubishi Tanabe Pharma recaps recent highlights

Recordati presents new metabotropic glutamate mGlu5 receptor antagonists

Novel vaccine against C. perfringens patented in India

New compounds extracted from Cymbidium disclosed by Kawano Mericlone

Cormus designs novel lipid-conjugated antibodies

Significant benefit seen with adalimumab in ulcerative colitis

Detailed results presented of phase III regorafenib study

Forest Laboratories and Gedeon Richter report phase III cariprazine data

Milestones achieved in Pepscan Therapeutics/Janssen R&D Ireland collaboration

RedHill receives approval from Health Canada to begin RHB-102 trial

GSK launches over-the-counter cold sore product in Europe

ImmunoCellular Therapeutics provides pipeline update

New stem cell therapy improves stroke outcome in preclinical models

Cytomedix completes acquisition

Wellcome Trust launches new scheme to fund early-stage research in orphan and neglected diseases

Prometheus Laboratories enters collaboration with leading pharmaceutical company

Moberg Derma analyzes phase II data on nail fungus therapy

Ironwood Pharmaceuticals gives update on linaclotide NDA

MRF to assess ENDECE Neural's myelin regenerative compounds for MS

Siemens enters partnerships with ViiV Healthcare and Tocagen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Sex differences shape gene activity across the human brain
BioWorld
Genes that are switched on or off in the human brain differ between men and women. Moreover, these differences are not uniform. They vary across cortical regions...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
Gilead Sciences patents new GTPase KRAS G12D inhibitors
BioWorld Science
Gilead Sciences Inc. has disclosed new GTPase KRAS G12D mutant inhibitors potentially useful for the treatment of cancer.